These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bempedoic acid, an inhibitor of ATP citrate lyase for the treatment of hypercholesterolemia: early indications and potential. Brandts J; Ray KK Expert Opin Investig Drugs; 2020 Aug; 29(8):763-770. PubMed ID: 32564642 [TBL] [Abstract][Full Text] [Related]
5. Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase. Bilen O; Ballantyne CM Curr Atheroscler Rep; 2016 Oct; 18(10):61. PubMed ID: 27663902 [TBL] [Abstract][Full Text] [Related]
6. Adenosine Triphosphate Citrate Lyase and Fatty Acid Synthesis Inhibition: A Narrative Review. Duarte Lau F; Giugliano RP JAMA Cardiol; 2023 Sep; 8(9):879-887. PubMed ID: 37585218 [TBL] [Abstract][Full Text] [Related]
8. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial. Goldberg AC; Leiter LA; Stroes ESG; Baum SJ; Hanselman JC; Bloedon LT; Lalwani ND; Patel PM; Zhao X; Duell PB JAMA; 2019 Nov; 322(18):1780-1788. PubMed ID: 31714986 [TBL] [Abstract][Full Text] [Related]
9. Role of Bempedoic Acid in Clinical Practice. Ballantyne CM; Bays H; Catapano AL; Goldberg A; Ray KK; Saseen JJ Cardiovasc Drugs Ther; 2021 Aug; 35(4):853-864. PubMed ID: 33818688 [TBL] [Abstract][Full Text] [Related]
10. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia. Banach M; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Flaim J; Ye Z; Catapano AL JAMA Cardiol; 2020 Oct; 5(10):1124-1135. PubMed ID: 32609313 [TBL] [Abstract][Full Text] [Related]
11. Mendelian Randomization Study of Ference BA; Ray KK; Catapano AL; Ference TB; Burgess S; Neff DR; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Kastelein JJP; Nicholls SJ N Engl J Med; 2019 Mar; 380(11):1033-1042. PubMed ID: 30865797 [TBL] [Abstract][Full Text] [Related]
12. Bempedoic acid (Nexletol) for lowering LDL-cholesterol. Med Lett Drugs Ther; 2020 Apr; 62(1595):53-55. PubMed ID: 32324179 [No Abstract] [Full Text] [Related]
13. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance. Laufs U; Banach M; Mancini GBJ; Gaudet D; Bloedon LT; Sterling LR; Kelly S; Stroes ESG J Am Heart Assoc; 2019 Apr; 8(7):e011662. PubMed ID: 30922146 [TBL] [Abstract][Full Text] [Related]
14. Role of Bempedoic Acid in Dyslipidemia Management. Kelly MS; Sulaica EM; Beavers CJ J Cardiovasc Pharmacol; 2020 Oct; 76(4):376-388. PubMed ID: 32732494 [TBL] [Abstract][Full Text] [Related]
15. Bempedoic Acid (ETC-1002): ATP Citrate Lyase Inhibitor: Review of a First-in-Class Medication with Potential Benefit in Statin-Refractory Cases. Zagelbaum NK; Yandrapalli S; Nabors C; Frishman WH Cardiol Rev; 2019; 27(1):49-56. PubMed ID: 29939848 [TBL] [Abstract][Full Text] [Related]
16. Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH). Agha AM; Jones PH; Ballantyne CM; Virani SS; Nambi V J Clin Lipidol; 2021; 15(5):649-652. PubMed ID: 34393074 [TBL] [Abstract][Full Text] [Related]
17. Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial. Lalwani ND; Hanselman JC; MacDougall DE; Sterling LR; Cramer CT J Clin Lipidol; 2019; 13(4):568-579. PubMed ID: 31202641 [TBL] [Abstract][Full Text] [Related]
18. Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial. Rubino J; MacDougall DE; Sterling LR; Kelly SE; McKenney JM; Lalwani ND J Clin Lipidol; 2021; 15(4):593-601. PubMed ID: 34172394 [TBL] [Abstract][Full Text] [Related]
19. ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: from preclinical studies to phase 3 trials. Ruscica M; Banach M; Sahebkar A; Corsini A; Sirtori CR Expert Opin Pharmacother; 2019 May; 20(7):791-803. PubMed ID: 30810432 [TBL] [Abstract][Full Text] [Related]
20. Bempedoic Acid: A New Drug for an Old Problem. Nguyen D; Du N; Sulaica EM; Wanat MA Ann Pharmacother; 2021 Feb; 55(2):246-251. PubMed ID: 32674598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]